HSCS 3.60 Heart Test Laboratories, Inc.
| Range: | 2.36-52.0 | Vol Avg: | 365387 | Last Div: | 0 | Changes: | 0.38 |
| Beta: | 3.19 | Cap: | 0.00B | Currency: | USD | Exchange: | NASDAQ |
| Sector: | Healthcare | IPO: | Thu Jun 16 2022 | Empoloyees: | 15 | ||
| CUSIP: | 42254E104 | CIK: | 0001468492 | ISIN: | US42254E1047 | Country: | US |
| CEO: | Mr. Andrew Simpson | Website: | https://heartsciences.com | ||||
Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional 12-lead resting ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.
Stock Details
Positive 0.28
HeartSciences to Participate in the 2024 Maxim Healthcare Virtual Summit
Southlake, TX, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a Hear...
globenewswire.com·Mon Oct 14 2024
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow